Rzepień pospolity ( Xanthium strumarium L.) – analiza i skład olejku eterycznego

otrzymano/received: 2009-09-25
zaakceptowano/accepted: 2009-11-02

Adres/address:
1. Wolski T, Zwolan W. Rzepień pospolity – chwast o właściwościach leczniczych. Wiad Ziel 2002; 44(11):20. 2. Zwolan W, Wolski T, Madej J i wsp. Chromatographic analysis of phenolic acids present in vegetative and generative parts of Xanthium strumarium L. Herba Pol 2004; 3/4:23-9. 3. Bown D. Wielka encyklopedia ziół. Muza, Warszawa, 1999, 222, 365, 372. 4. Wolski T, Zwolan W, Lewandowska A. Rzepień pospolity ( Xanthium strumarium L.) surowiec zielarski o wielokierunkowym działaniu farmakologicznym. Analiza fitochemiczna związków fenolowych. Post Fitoter 2006; 7(3):118-30. 5. Wolski T, Zwolan W, Baj T i wsp. Rzepień pospolity ( Xanthium strumarium L.) – Analiza fitochemiczna steroli i triterpenów. Post Fitoter. 2006; 7:4. 6. Zwolan W. Rozprawa doktorska. UM w Lublinie, 2007. 7. Weryszko-Chmielewska E, Zwolan W, Wolski T i wsp. Koncentracja pyłku Xanthium strumarium L.w aeroplanktonie Lublina w latach 2003-2005. Acta Agrobot 2006; 59(2):141-51. 8. Dharmananda S. Safety issues affecting Chinese herbs: the case of Xanthium. http://www.itmonline.org/arts//xanthium.htm. 9. Plants for a future. http://www.scs.leeds.ac.uk//cgi-bin/pfaf/arr_html?Xanthium+ strumarium &CAN=LATIND. 10. Sarwa AJ. Wielki leksykon roślin leczniczych. Książka i Wiedza, Warszawa 2001; 386. 11. Dharmananda S. Appendix: Xanthium in traditional and modern Chinese medical practice. http://www.itmonline.org./arts/xanthium.html. 12. Dharmananda S. Gallnuts and the uses of tannins in Chinese medicine. http://www.itmonline.org/arts/gallnuts.htm. 13. Kim YS, Kim JS, Park SH i wsp. Two cytotoxic sesquiterpene lactones from the leaves of Xanthium strumarium and their in vitro inhibitory activity on farnesyltransferase. Planta Med 2003; 69:375-7. 14. Mehta P, Chopra S, Mahta A. Antimicrobial properties of some plant extracts against bacteria. Folia Microbiol 1983; 28(6):467-9. 15. Aggarwal BB, Seti G, Nair A i wsp. Nuclear factor – kB: a holly grail in cancer prevention and therapy. Current Signal Transduction Therapy 2006; 1:25-52. 16. Lavault M, Landreau A, Larcher G i wsp. Antileishmanial and antifungal activities of xanthanolides isolated from Xanthium marcoaprum. Fitoter 2005; 76:363-6. 17. Moon EY, Park SY, Ahn MJ. Immunomodulating activities of water extract from Xanthium strumarium (II): Immunomodulating effects of the water layer after treated with chloroform. Arch Pharm Res 1991; 14:217-24. 18. Roussakis C, Chinou I, Vayas C i wsp. Cytotoxic activity of xanthatin and the crude extracts of Xanthium strumarium. Planta Med 1994; 60:473-4. 19. Sato Y, Oketani H, Yamada T i wsp. A xanthanolide with potent antibacterial activity against methicillin-resistant Staphylococcus aureus. Pharm Pharmacol 1997; 49:1042-44. 20. Tripathi RN, Dubey NK, Dixit SN. Fungitoxicity of pollen grains with special reference to Xanthium strumarium ( Compositae). Grana 1985; 24(1):61-3. 21. Kim IT, Park YM, Won JH i wsp. Methanol extract of Xanthium strumarium L. possesses anti-inflamatory and anti-nociceptive activities. Biol Pharm Bull 2005; 28:94-100. 22. Cai Y, Qiong L, Mey S i wsp. Antioxidant activity and phenolic compounds of 112 traditional Chinese medicinal plants associated with anticancer. Life Sci 2004; 74:2157-84. 23. Hong CH, Hur SK, Oh OJ i wsp. Evaluation of natural products on inhibition of inducible cyclooxygenase (COX-2) and nitric oxide synthase (iNOS) in cultured mouse macrophage cells. J Ethnopharmacol 2002; 83:153-9. 24. Kang GD, Yun C, Lee HS i wsp. Screening and comparison of antioxidant activity of solvent extracts of herbal medicines used in Korea. J. Ethnopharmacol 2003; 87:231-6. 25. Lae HJ. Inhibition of nitric oxide synthesis by 8-epi-xanthatin in PLS-activated macrophages. Yakhak Hoechi 1998; 42:540-4. 26. Prieto JM, Martini F, Bader A i wsp. Identification of a 5-LOX inhibitor from Xanthium spinosum L. Rev. Fitoterapia. Anual Congres Barcelona 2002, p. 110. 27. Shale TL, Strik WA, van Staden J. Screening of medicinal plants used in Lesotho for anti-bacterial and anti-inflammatory activity. J. Ethnopharmacol 1999; 67:347-54. 28. Coelho de Souza G, Haas APS, von Poser GL i wsp. Ethnopharmacological studies of antimicrobial remedies in the south of Brazil. J. Ethnopharmacol 2004; 90:135-43. 29. Pinel B, Landreau A, Seraphin D i wsp. Synthesis of reduced xanthatin derivatives and in vitro evaluation of their antifungal activity. J Enzyme Inhibit Med Chem 2005; 20:575-9. 30. Nairman F, Eftekhar F, Habibi Z i wsp.: Anti- Helicobacter pylori activities of six Iranian plants. J. Etnopharmacol 2004; 9(2):146-51. 31. Felther HW. The eclectic materia medica, pharmacognosy & terapeutics. http://www.vu.edu.au/library/pdf/5science postgraduate subjects.pdf. 32. Li Y, Xu C, Zhang Q i wsp. In vitro anti- Helicobacter pylori action of 30 Chinese herbal medicines uses to treat ulcer diseases. J Ethnopharmacol 2005; 98(3):329-33. 33. Wang YC, Huang TL. Screening of anti- Helicobacter pylori herbs deriving from Taiwanese folk medicinal plants. FEMS Immunol Med Microbiol 2005; 43(2):295-300. 34. Abdel-Malek S, Bastien JW, Mahler WF i wsp. Drug leads from the Kallawaya herbalists of Bolivia. 1. Background, rationale, protocol and anti-HIV activity. J Ethnopharmacol 1996; 50(3):157-66. 35. Talkal TS, Dwivedi SK, Sharma SR. In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves. J Ethnopharmacol 1995; 49(3):141-5. 36. Talkal TS. In vitro and in vivo antitrypanosomal activity of Xanthium strumarium leaves and Parthenium hysterophorus flowers. Indian-Drugs 1995; 32:433. 37. Rocha LG, Almeida JRGS, Macedo RO i wsp. A review of natural products with antileishmanial activity. Phytomed 2005; 12(6):514-35. 38. Kawazu K, Nakajima S, Ariwa M. Xanthatin and 8-epi-xanthatin as insect development inhibitors from Xanthium candense Mill. Experientia 1979; 35:1294-5. 39. Kupiecki FP, Ogzewalla CD, Schell FM. Isolation and characterization of a hypoglycemic compound from Xanthium strumarium. J Pharm Sci 1974; 63:1166-7. 40. Hsu FL, Hen YC, Heng JT. Cafeic acid as a active principle from the fruit of Xanthium strumarium to lower plasma glucose in diabetic rats. Planta Med 2000; 66(3):228-30. 41. Li WL, Zheng HC, Bukuru J i wsp. Natural medicines used in the traditional Chinese medical system for therapy of diabetes mellitus. J Ethnopharmacol 2004; 92:1-21. 42. Turner CE, Craig JC. Hypoglycemic compound and method of preparing. United States Patent, number: US 3922263. 43. Sucher NJ. Insights from molecular investigations of traditional Chinese herbal stroke medicines: Implications for neuroprotective epilepsy therapy. Epilepsy Behav 2006; 8(2):350-62. 44. Balachandran P, Govindarajan R. Cancer – an ayurvedic perspective. Pharm Res 2005; 51(1):19-30. 45. Graham JG, Quinn ML, Fabricant DS i wsp. Plants used against cancer – an extension of the work of Jonathan Hartwell. J Ethnopharmacol 2000; 73(3):347-77. 46. Murillo-Alvarez JI, Encarnación DR, Franzblau SG i wsp. Antimicrobial and cytotoxic activity of some medicinal plants from Baja California Sur (Mexico). Pharm Biol 2001; 39(6):445-9. 47. Ancuceanu RV. Pharmacologically active natural compounds for lung cancer. Alt Med Rev 2004; 9(4):402-19. 48. Menon GS, Kuchroo K, Dasgupta D. Interaction of microtubules with active principles of Xanthium strumarium. Phys Chem Phys Med NMR 2001; 33(2):153-62. 49. Cole RJ, Stuard BP, Lansden JA i wsp. Isolation and redefinition of the toxic agent from cocklebur ( Xanthium strumarium). J Agric Food Chem 1980; 28(6):1330-2. 50. Hatch RC, Jain AV, Weiss R i wsp. Toxicologic study of carboxyatractyloside (active principle in coclebur – Xanthium strumarium) in rats treated with enzyme indecers and inhibitors and glutathione precursor and depletor. Am J Vet Res 1982; 43: 111-6. 51. Luciani S, Varotto R. Difference between atractyloside and carboxyatractyloside on the binding to the mitochondrial membrane. Febs Lett 1975; 56:194-7. 52. MacLeod JK, Moeller PD, Franke FP. Two cytotoxic kaurene glycosides from the burrs of Xanthium purgens. J Nat Prod 1990; 53(2):451-5. 53. Steward MJ, Steenkamp V. The biochemistry and toxicity of atractyloside. A review. Ther Drug Monit 2000; 22(6):641-9. 54. Kephalas T, Alikaridis F, Pantelia K i wsp. Production of carboxyatractyloside and atractyloside by cell suspension cultures of Atractylis gummifera. Phytochem 1999; 51(1):53-4. 55. Gailard Y, Pepin G. Poisoning by plant material: rewiev of human cases and analytical determination of main toxins by high-performance liquid chromatography – (tandem) mass spectrometry. J Chromatogr B 1999; 733(1):181-229. 56. Stuart BP, Cole RJ, Gosser HS. Cocklebur ( Xanthium strumarium L. var. strumarium) intoxication in swine: review and redefinition of the toxic principle. Vet Pathol 1981; 18(3):368-83. 57. Turgut M, Alhan CC, Gurgoze M i wsp. Carboxyatractyloside poisoning in humans. Ann Ter Ped 2005; 25(2):125-34. 58. Ailmets senses – treasure of east. http://www.treasureofeast.com/fromulas.html. 59. Balance healthcare. Products, services and support for profesionals. http://www.balanceheatlhcare.com/subCat.aps?subCat_id=1. 60. China–West #06 Children Xanthium Formula. http://www.nutriwest.com/cat/cw-0006.html. 61. Commitee on Chinese Medicine and Pharmacy, Department of Health, Taiwan. http://www.ccmp.gov.tw/en/information/formula.asp?relno=52&selno=0&no=&PageNo=10. 62. Jade Screen & Xanthium Formula. http://www.spanda.com/herbs/golden/jsx.html. 63. Mengjun Y. Nano Medicine ´Huodan Biyan´ nad its preparing process. United States Patent Number: CN 1368349. 64. Zhang Y, Zhang J. Preparation method of Xanthium sibiricum volatile oil pharmaceutical. United States Patent Number: CN 1053364. 65. Seaman FC. Sesquiterpene lactones as taxonomic characters in Asteraceae. Bot Rev 1982; 48:121-595. 66. Kohlműnzer S. Farmakognozja. PZWL, Warszawa, 2000. 67. Lersten NR, Curtis JD. Secretory reservoirs (duct) development in Ambrosia trifida ( Asteraceae) staminate flowers. Amer J Bot 1988; 76(7):1313-23. 68. Maksymowych R, Ledbetter MC. Fine structure of epithelial canal cell in petioles of Xanthium pensylvanicum. Amer J Bot 1987; 74(1):65-73. 69. Lersten NR, Curtis JD. Polyacetylene reservoir (duct) development in Ambrosia trifida ( Asteraceae) staminate flowers. Amer J Bot 1989; 76(7):1000-5. 70. Farmakopea Polska VI, PTFarm, Warszawa, 2002. 71. PN-91/R-87019, Surowce zielarskie. Pobieranie próbek i metody badań. PKNMiJ. 1991. 72. Deibler KD, Lavin EH, Acree TE. Solid phase microextraction application in GC/olfactometry dilution analysis.w (rd.) Jackson J.F. and Linskens H.F. Springer-Verlag, Berlin, Heidelberg, 2002. 73. Joulian D, Köning WA. The atlas of spectral data of sesquiterpene hydrocarbons. E. B. Verlag. Hamburg, 1998; p. 658. 74. Finningan MAT. Terpene Library. Finningan: Electronic Database, USA, 1990. 75. NIST/EPA/NIH. Mass Spectral Libraly. National Institute of Standarts and Technology: Electronic Database, USA, 2002. 76. Adams RP, Identification of essential oil compounds by gas chromatography /quadrupole mas spectroscopy. Alluredd Publishing Corporation Carol Stream III, USA. 2004. 77. Ahijja MM, Nigam SS. Chemical examination of the essential oil from the leaves of Xanthium strumarium (Linn.). Flav Ind 1970; 1:627-30. 78. Habibi Z, Laleh A, Masoudi S i wsp. Composition of the essential oil of Xanthium brasilicum vellozo from Iran. J Essent Oil Res 2004; 16:31-2. 79. Kapoor VK, Chawla AK, Bedi K. Studies on the oil of Xanthium strumarium. J Am Oil Chem Soc 1976; 53(8):524. 80. Chu TR, Wei YC. Studies on the principal unsaturated fatty AIDS of the seed oil of Xanthium strumarium L. Yao Xue Xue Bao, 1965; 12(11):709-12. 81. Dayal B, Purohit RM. Screening of some Indian essential oils for their antifungal properties. Flav Ind 1971; 2:484-5.